ArticleThe Journal of pathology2012

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.

Badreddin Edris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.